Quarterly ResultJul 30, 2026, 07:02 AM
Haleon H1 Adj. Operating Profit +8.2%, Adj. EPS +12.0%; Dividend +9%
AI Summary
Haleon plc reported strong half-year results for 2026, with adjusted operating profit increasing 8.2% at constant currency to £1,364m and adjusted diluted EPS rising 12.0% to 10.3p. Reported revenue grew 2.2% to £5,602m, driven by 2.6% organic growth. The company declared an interim dividend of 2.4p per share, a 9% increase, and completed £457m of its £500m share buyback program for 2026. Haleon maintained its FY 2026 outlook, expecting organic revenue growth of 3-5% and high single-digit adjusted operating profit growth.
Key Highlights
- H1 2026 Adjusted Operating Profit: £1,364m, +8.2% at constant currency.
- H1 2026 Adjusted Diluted EPS: 10.3p, up 12.0%.
- H1 2026 Reported Revenue: £5,602m, +2.2% (+2.6% organic).
- Interim Dividend: 2.4p per share, a 9% increase from 2025.
- Share Buyback: £457m completed out of £500m allocated for 2026.
- Net Debt/Adjusted EBITDA: 2.5x as of June 30, 2026.
- FY 2026 Outlook: Organic revenue growth 3-5%, high single-digit adjusted operating profit growth.
- Oral Health Revenue: £1,838m, +7.3% organic growth.
Price Impact
More from HLN